Telix Pharmaceuticals Ltd

NEW
FRA:T3X (Australia)   Ordinary Shares
€ 9.37 +0.39 (+4.3%) Jul 21
At Loss
P/B:
8.66
Market Cap:
€ 3.10B ($ 3.53B)
Enterprise V:
€ 3.38B ($ 3.86B)
Volume:
0
Avg Vol (2M):
940.00
Trade In:

Telix Pharmaceuticals Ltd Valuation Measures